· Updated daily
Independent — we sell nothingSubscribe
Topic hub
The documented adverse effects, the risks that come from the gray market rather than the compound, and what is simply unknown.
Hub introduction not published yet
The section index below is generated from the keyword map, so it is accurate regardless.
Not all "evidence" carries the same weight. Every safety claim on this site is tagged by the kind of evidence behind it.
Findings from controlled human trials and regulatory safety data. The strongest basis for a claim.
Cell or animal studies only. Suggestive, but not yet shown to translate to humans — read with caution.
Individual reports and forum testimony. Useful for hypotheses, not proof. Never a substitute for trial data.
The beat
Safety
BPC-157 safety, as FDA staff set it out for the July 2026 compounding advisory meeting: quality, immunogenicity and missing human data. No final decision.
